Methods for treating cancers using polymorphic forms of 3-(4-amino-1-oxo-1,3-dihydroisoindol-2yl)-piperidine-2,6-dione

Details for Australian Patent Application No. 2004240548 (hide)

International Classifications

Event Publications

12 January 2006 PCT application entered the National Phase

PCT publication WO2004/103274 Priority application(s): WO2004/103274

2 February 2006 Amendment Made

The nature of the amendment is: Add priority details 60/499,723 04 Sep 2003 US 2004244038 Muscle Tech Ltd. The nature of the amendment is as shown in the statement(s) filed 29 Dec 2005

5 November 2009 Application Accepted

Published as AU-B-2004240548

28 January 2010 Application for Amendment

The nature of the amendment is: Add coinventors Jaworsky, Markian S.; Muller, George W.; Cameron, Louise M.; Chen, Roger Shen-Chu; Saindane, Manohar T.. Address for service in Australia - Phillips Ormonde Fitzpatrick 367 Collins Street Melbourne VIC 3000

20 May 2010 Amendment Made

The nature of the amendment is: Add co-inventors Jaworsky, Markian S.; Muller, George W.; Cameron, Louise M.; Chen, Roger Shen-Chu; Saindane, Manohar T.

3 June 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.